Novel Therapeutic Approaches to Prevent Atherothrombotic Ischemic Stroke in Patients with Carotid Atherosclerosis

Atherothrombotic stroke represents approximately 20% of all ischemic strokes. It is caused by large-artery atherosclerosis, mostly in the internal carotid artery, and it is associated with a high risk of early recurrence. After an ischemic stroke, tissue plasminogen activator is used in clinical pra...

Descripción completa

Detalles Bibliográficos
Autores principales: Puig, Núria, Solé, Arnau, Aguilera-Simon, Ana, Griñán, Raquel, Rotllan, Noemi, Camps-Renom, Pol, Benitez, Sonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531661/
https://www.ncbi.nlm.nih.gov/pubmed/37762627
http://dx.doi.org/10.3390/ijms241814325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531661/
https://www.ncbi.nlm.nih.gov/pubmed/37762627
http://dx.doi.org/10.3390/ijms241814325

Ejemplares similares